SBI-100 Ophthalmic Emulsion, 0.5%

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye PressureNCT06144918SKYEPhase 2Completed2024-02-22Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.